PMC:7556165 / 67390-68368 JSONTXT

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T186","span":{"begin":101,"end":110},"obj":"Chemical"},{"id":"T187","span":{"begin":449,"end":458},"obj":"Chemical"},{"id":"T188","span":{"begin":551,"end":560},"obj":"Chemical"},{"id":"T189","span":{"begin":767,"end":776},"obj":"Chemical"}],"attributes":[{"id":"A187","pred":"chebi_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/CHEBI_27300"},{"id":"A186","pred":"chebi_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/CHEBI_27300"},{"id":"A189","pred":"chebi_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/CHEBI_27300"},{"id":"A188","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_27300"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T373","span":{"begin":75,"end":85},"obj":"Species"},{"id":"T374","span":{"begin":75,"end":79},"obj":"Species"},{"id":"T375","span":{"begin":278,"end":286},"obj":"Species"},{"id":"T376","span":{"begin":463,"end":473},"obj":"Species"},{"id":"T377","span":{"begin":463,"end":467},"obj":"Species"},{"id":"T378","span":{"begin":506,"end":516},"obj":"Species"},{"id":"T379","span":{"begin":506,"end":510},"obj":"Species"},{"id":"T380","span":{"begin":879,"end":889},"obj":"Species"},{"id":"T381","span":{"begin":879,"end":883},"obj":"Species"}],"attributes":[{"id":"A378","pred":"ncbi_taxonomy_id","subj":"T378","obj":"NCBItxid:2697049"},{"id":"A373","pred":"ncbi_taxonomy_id","subj":"T373","obj":"NCBItxid:2697049"},{"id":"A374","pred":"ncbi_taxonomy_id","subj":"T374","obj":"NCBItxid:694009"},{"id":"A380","pred":"ncbi_taxonomy_id","subj":"T380","obj":"NCBItxid:2697049"},{"id":"A377","pred":"ncbi_taxonomy_id","subj":"T377","obj":"NCBItxid:694009"},{"id":"A379","pred":"ncbi_taxonomy_id","subj":"T379","obj":"NCBItxid:694009"},{"id":"A381","pred":"ncbi_taxonomy_id","subj":"T381","obj":"NCBItxid:694009"},{"id":"A375","pred":"ncbi_taxonomy_id","subj":"T375","obj":"NCBItxid:2697049"},{"id":"A376","pred":"ncbi_taxonomy_id","subj":"T376","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T399","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T400","span":{"begin":160,"end":321},"obj":"Sentence"},{"id":"T401","span":{"begin":322,"end":978},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1849","span":{"begin":75,"end":85},"obj":"Species"},{"id":"1850","span":{"begin":463,"end":473},"obj":"Species"},{"id":"1851","span":{"begin":506,"end":516},"obj":"Species"},{"id":"1852","span":{"begin":879,"end":889},"obj":"Species"},{"id":"1853","span":{"begin":101,"end":110},"obj":"Chemical"},{"id":"1854","span":{"begin":235,"end":250},"obj":"Disease"},{"id":"1855","span":{"begin":278,"end":286},"obj":"Disease"},{"id":"1856","span":{"begin":598,"end":613},"obj":"Disease"},{"id":"1857","span":{"begin":620,"end":640},"obj":"Disease"},{"id":"1858","span":{"begin":697,"end":719},"obj":"Disease"},{"id":"1859","span":{"begin":904,"end":913},"obj":"Disease"}],"attributes":[{"id":"A1852","pred":"pubann:denotes","subj":"1852","obj":"Tax:2697049"},{"id":"A1850","pred":"pubann:denotes","subj":"1850","obj":"Tax:2697049"},{"id":"A1849","pred":"pubann:denotes","subj":"1849","obj":"Tax:2697049"},{"id":"A1857","pred":"pubann:denotes","subj":"1857","obj":"MESH:D012141"},{"id":"A1855","pred":"pubann:denotes","subj":"1855","obj":"MESH:C000657245"},{"id":"A1851","pred":"pubann:denotes","subj":"1851","obj":"Tax:2697049"},{"id":"A1853","pred":"pubann:denotes","subj":"1853","obj":"MESH:D014807"},{"id":"A1858","pred":"pubann:denotes","subj":"1858","obj":"MESH:D012141"},{"id":"A1859","pred":"pubann:denotes","subj":"1859","obj":"MESH:D003643"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T270","span":{"begin":57,"end":71},"obj":"http://purl.obolibrary.org/obo/IDO_0000467"},{"id":"T271","span":{"begin":630,"end":640},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T272","span":{"begin":709,"end":719},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T448","span":{"begin":826,"end":834},"obj":"Body_part"}],"attributes":[{"id":"A448","pred":"fma_id","subj":"T448","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T388","span":{"begin":75,"end":85},"obj":"Disease"},{"id":"T389","span":{"begin":75,"end":79},"obj":"Disease"},{"id":"T390","span":{"begin":235,"end":252},"obj":"Disease"},{"id":"T391","span":{"begin":278,"end":286},"obj":"Disease"},{"id":"T392","span":{"begin":463,"end":473},"obj":"Disease"},{"id":"T393","span":{"begin":463,"end":467},"obj":"Disease"},{"id":"T394","span":{"begin":506,"end":516},"obj":"Disease"},{"id":"T395","span":{"begin":506,"end":510},"obj":"Disease"},{"id":"T396","span":{"begin":598,"end":615},"obj":"Disease"},{"id":"T397","span":{"begin":630,"end":640},"obj":"Disease"},{"id":"T398","span":{"begin":697,"end":719},"obj":"Disease"},{"id":"T399","span":{"begin":879,"end":889},"obj":"Disease"},{"id":"T400","span":{"begin":879,"end":883},"obj":"Disease"}],"attributes":[{"id":"A397","pred":"mondo_id","subj":"T397","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A393","pred":"mondo_id","subj":"T393","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A398","pred":"mondo_id","subj":"T398","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A399","pred":"mondo_id","subj":"T399","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A400","pred":"mondo_id","subj":"T400","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A395","pred":"mondo_id","subj":"T395","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A394","pred":"mondo_id","subj":"T394","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A391","pred":"mondo_id","subj":"T391","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A396","pred":"mondo_id","subj":"T396","obj":"http://purl.obolibrary.org/obo/MONDO_0005520"},{"id":"A389","pred":"mondo_id","subj":"T389","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A390","pred":"mondo_id","subj":"T390","obj":"http://purl.obolibrary.org/obo/MONDO_0005520"},{"id":"A388","pred":"mondo_id","subj":"T388","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A392","pred":"mondo_id","subj":"T392","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T70","span":{"begin":101,"end":121},"obj":"Phenotype"},{"id":"T71","span":{"begin":620,"end":640},"obj":"Phenotype"},{"id":"T72","span":{"begin":697,"end":719},"obj":"Phenotype"},{"id":"T73","span":{"begin":826,"end":840},"obj":"Phenotype"}],"attributes":[{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0100512"},{"id":"A73","pred":"hp_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A72","pred":"hp_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A71","pred":"hp_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/HP_0006532"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T73","span":{"begin":101,"end":121},"obj":"Phenotype"},{"id":"T74","span":{"begin":620,"end":640},"obj":"Phenotype"},{"id":"T75","span":{"begin":697,"end":719},"obj":"Phenotype"},{"id":"T76","span":{"begin":826,"end":840},"obj":"Phenotype"}],"attributes":[{"id":"A73","pred":"hp_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/HP_0100512"},{"id":"A74","pred":"hp_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/HP_0006532"},{"id":"A75","pred":"hp_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1849","span":{"begin":75,"end":85},"obj":"Species"},{"id":"1850","span":{"begin":463,"end":473},"obj":"Species"},{"id":"1851","span":{"begin":506,"end":516},"obj":"Species"},{"id":"1852","span":{"begin":879,"end":889},"obj":"Species"},{"id":"1853","span":{"begin":101,"end":110},"obj":"Chemical"},{"id":"1854","span":{"begin":235,"end":250},"obj":"Disease"},{"id":"1855","span":{"begin":278,"end":286},"obj":"Disease"},{"id":"1856","span":{"begin":598,"end":613},"obj":"Disease"},{"id":"1857","span":{"begin":620,"end":640},"obj":"Disease"},{"id":"1858","span":{"begin":697,"end":719},"obj":"Disease"},{"id":"1859","span":{"begin":904,"end":913},"obj":"Disease"}],"attributes":[{"id":"A1849","pred":"tao:has_database_id","subj":"1849","obj":"Tax:2697049"},{"id":"A1850","pred":"tao:has_database_id","subj":"1850","obj":"Tax:2697049"},{"id":"A1851","pred":"tao:has_database_id","subj":"1851","obj":"Tax:2697049"},{"id":"A1852","pred":"tao:has_database_id","subj":"1852","obj":"Tax:2697049"},{"id":"A1853","pred":"tao:has_database_id","subj":"1853","obj":"MESH:D014807"},{"id":"A1855","pred":"tao:has_database_id","subj":"1855","obj":"MESH:C000657245"},{"id":"A1857","pred":"tao:has_database_id","subj":"1857","obj":"MESH:D012141"},{"id":"A1858","pred":"tao:has_database_id","subj":"1858","obj":"MESH:D012141"},{"id":"A1859","pred":"tao:has_database_id","subj":"1859","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T399","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T400","span":{"begin":160,"end":321},"obj":"Sentence"},{"id":"T401","span":{"begin":322,"end":978},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other conditions have been assumed to be involved in the susceptibility to SARS-CoV-2 and among them vitamin D deficiency was proposed as a credible candidate. The interesting candidate could be identified as a modifiable risk factor (hypovitaminosis D) and a potential tool in COVID-19 prevention or ancillary treatment. The rationale has been summarized by Grant et al. in a recent review on the evidence supporting a possible correlation between vitamin D and SARS-CoV-2 risk: (i) the seasonal flare of SARS-CoV-2 which coincides with the nadir of vitamin D levels, (ii) the association between hypovitaminosis D and pulmonary infections together with the demonstrated protective role in acute respiratory infections, in adults (iii) the anti-inflammatory role of vitamin D which could be of benefit against the so called “cytokine storm,” which seems to be a major player in SARS-CoV-2 morbidity and mortality (Martineau et al., 2017; Zhou et al., 2019; Grant et al., 2020)."}